Genomics, Inc. , the life science technology leader focused on accelerating science and advancing human health, announced it will report financial results for the second quarter ended June 30, 2026 ...

Discover promising genetic sequencing stocks and stay ahead in the genomics revolution. Learn which companies are driving DNA technology forward.

IRC §41(b)(2)(A)(iii) allows businesses to count amounts paid for the right to use computers in qualified research as ...

Genomics tools—fine-tuned and applied to agriculture—create commercially desirable traits in a fraction of the time required ...

Levi & Korsinsky, LLP highlights the contrast between GeneDx Holdings Corp.'s (NASDAQ: WGS) promises to investors and the ...

For decades, cancer has been thought of as a purely human disease—rogue cells multiplying out of control, with no room for ...

Upload a next-generation sequencing report from any lab and get one unified, AMP/ASCO/CAP-tiered, citation-backed read.

Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D. , as its Chief Scientific Officer (CSO) , effective July 20, 2026.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) conference grew substantially compared ...

A new preprint shows vector-similarity search can treat clinically distinct cancer variants as the same, and a typed ...

Cross-vendor NGS interpretation, genomics-aware decision support, trial matching, and prior authorization, with every ...